Development of BEN8744, a phase 2 ready, peripherally restricted PDE10 inhibitor targeting a new mechanism of action for the treatment of ulcerative colitis.JOURNAL OF CROHNS & COLITISIF8.72025-01-220PRE
Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) SynthesisJOURNAL OF MEDICINAL CHEMISTRYIF6.82017-02-0395PREAI
In Silico-Based High-Throughput Screen for Discovery of Novel Combinations for Tuberculosis TreatmentANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52015-09-019OAAI
Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidateNATURE COMMUNICATIONSIF15.72015-03-3161OAAI
1,4-Azaindole, a Potential Drug Candidate for Treatment of TuberculosisANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52014-09-0197OAAI
N-Aryl-2-aminobenzimidazoles: Novel, Efficacious, Antimalarial Lead CompoundsJOURNAL OF MEDICINAL CHEMISTRYIF6.82014-07-2138PREAI
Aminoazabenzimidazoles, a Novel Class of Orally Active Antimalarial AgentsJOURNAL OF MEDICINAL CHEMISTRYIF6.82014-06-2425PREAI
Lead Optimization of 1,4-Azaindoles as Antimycobacterial AgentsJOURNAL OF MEDICINAL CHEMISTRYIF6.82014-06-2077PREAI
4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial ActivityJOURNAL OF MEDICINAL CHEMISTRYIF6.82014-06-1186PREAI